OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
Clinical trial NCT00040183 · COMPLETED
Trial details
- NCT number
- NCT00040183
- Sponsor
- OSI Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-29
- Primary completion
- 2004-01-15
- Enrollment
- 569
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.